PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31828866-9	2020	Moreover, Scu reduced hepatocyte steatosis, decreased lipid accumulation and triglyceride levels, inhibited mTOR phosphorylation, and decreased the SREBP-1c level in the liver.	scutellarin	10-13	sterol regulatory element binding transcription factor 1	Homo sapiens	148-156	
31828866-0	2020	Scutellarin, a modulator of mTOR, attenuates hepatic insulin resistance by regulating hepatocyte lipid metabolism via SREBP-1c suppression.	scutellarin	0-11	sterol regulatory element binding transcription factor 1	Homo sapiens	118-126	
31828866-7	2020	Moreover, Scu downregulated mammalian target of rapamycin (mTOR) phosphorylation and the n-SREBP-1c protein level and also reduced lipid accumulation via the mTOR-dependent pathway, as confirmed by the molecular docking of Scu to mTOR.	scutellarin	10-13	sterol regulatory element binding transcription factor 1	Homo sapiens	91-99	
34859513-4	2022	Scu reduced intracellular lipid content and inhibited sterol regulatory element binding protein-1c (SREBP-1c)-mediated lipid synthesis and fatty acid translocase-mediated lipid uptake in HepG2 cells.	scutellarin	0-3	sterol regulatory element binding transcription factor 1	Homo sapiens	54-98	
34859513-4	2022	Scu reduced intracellular lipid content and inhibited sterol regulatory element binding protein-1c (SREBP-1c)-mediated lipid synthesis and fatty acid translocase-mediated lipid uptake in HepG2 cells.	scutellarin	0-3	sterol regulatory element binding transcription factor 1	Homo sapiens	100-108	
31828866-10	2020	Taken together, these findings suggest that Scu ameliorates hepatic IR by regulating hepatocyte lipid metabolism via the mTOR-dependent pathway through SREBP-1c suppression.	scutellarin	44-47	sterol regulatory element binding transcription factor 1	Homo sapiens	152-160